Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2009
09/24/2009US20090239241 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
09/24/2009US20090239237 METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM
09/24/2009US20090239236 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
09/24/2009US20090239235 Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins
09/24/2009US20090239234 Identification and/or quantification method of nucleotide sequence(s) elements specific of genetically modified plants on arrays
09/24/2009US20090239233 Single-tube, ready-to-use assay kits, and methods using same
09/24/2009US20090239232 Methods of rna amplification in the presence of dna
09/24/2009US20090239231 RNA From Cytology Samples To Diagnose Disease
09/24/2009US20090239230 Lung Cancer Diagnosis Based on Expression Levels of GIMAP Genes
09/24/2009US20090239229 DNA Repair Proteins Associated With Triple Negative Breast Cancers and Methods of Use Thereof
09/24/2009US20090239228 Chimeric promoter molecules for gene expression in prokaryotes
09/24/2009US20090239227 Method of diagnosing risk of myocardial infarction
09/24/2009US20090239226 Markers for breast cancer
09/24/2009US20090239225 Prediction and diagnosis of canine degenerative myelopathy
09/24/2009US20090239224 Methods for identifying bioagents
09/24/2009US20090239223 Prediction of Breast Cancer Response to Taxane-Based Chemotherapy
09/24/2009US20090239222 Composition for nucleic-acid transfection
09/24/2009US20090239221 diagnostic markers and clinical targets for prostate cancer; androgen regulated genes and ETS family member genes
09/24/2009US20090239220 Dlc-1 gene deleted in cancers
09/24/2009US20090239219 Telomerase expression repressor proteins and methods of using the same
09/24/2009US20090239218 Method for the diagnosis and treatment of cardiovascular diseases
09/24/2009US20090239217 Stem-like cells in bone sarcomas
09/24/2009US20090239216 Novel Tannase Gene And Protein Thereof
09/24/2009US20090239215 Clonable Tag for Purification and Electron Microscopy Labeling
09/24/2009US20090239214 Prognosis of breast cancer patients
09/24/2009US20090239213 Identifying a target polynucleotide
09/24/2009US20090239212 Screening for the Genetic Defect Causing Tibial Hemimelia in Bovines
09/24/2009US20090239211 Method For Enrichment Involving Elimination By Mismatch Hybridisation
09/24/2009US20090239210 Proteins recruited by virus during infection of plants and method for their isolation and identification
09/24/2009US20090239207 Method of assessing the viability of thawed cells
09/24/2009US20090238896 Compositions and methods for diagnosing and treating melanoma
09/24/2009US20090238841 Hiv vaccine formulations
09/24/2009US20090238836 Hip kinase for fertility control
09/24/2009US20090238833 Protein
09/24/2009US20090238832 Novel compositions and method for the treatment of psoriasis
09/24/2009US20090238819 Therapeutic and diagnostic agents
09/24/2009US20090238817 Anti-cell proliferative compounds and methods of use
09/24/2009US20090238804 Use of cells containing a specific dna molecule as cytopathic agents to inhibit the proliferation of cells
09/24/2009US20090238798 Nucleotide Sequences Encoding Insecticidal Proteins
09/24/2009US20090238774 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
09/24/2009US20090238772 Methods and compositions for prevention or treatment of rsv infection
09/24/2009US20090238726 Quantification of analytes using internal standards
09/24/2009US20090237262 Analyte testing method and system
09/24/2009US20090237067 Detect and identify virus by the microwave absorption spectroscopy
09/24/2009US20090236225 Microrna detection
09/24/2009US20090235746 Detecting And Measuring Live Pathogens Utilizing A Mass Detection Device
09/24/2009DE112007002921T5 Vorrichtung und Verfahren zur Cholesterinbestimmung Apparatus and method for cholesterol determination
09/24/2009DE102008000715A1 Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen Method for the in vitro differentiation of pathophysiological states and Erfasssung
09/24/2009DE102005052384B4 Verfahren zur Erkennung, Markierung und Behandlung von epithelialen Lungentumorzellen sowie Mittel zur Durchführung des Verfahrens Method for detecting, marking and treating epithelial lung tumor cells as well as means for performing the method
09/24/2009CA2718946A1 Non-competitive internal controls for use in nucleic acid tests
09/24/2009CA2718905A1 Expression-linked gene discovery
09/24/2009CA2718904A1 Combined chemical and genetic approaches for generation of induced pluripotent stem cells
09/24/2009CA2718887A1 Genetic analysis
09/24/2009CA2718869A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
09/24/2009CA2718741A1 Method for the in vitro detection and differentiation of pathophysiological conditions
09/24/2009CA2718708A1 Genetic indicators of weight loss
09/24/2009CA2718687A1 Process and system for detecting and/or quantifying bacteriophages capable of infecting a predetermined bacterial host strain, use of a microelectronic sensor device for detectingsaid bacteriophages and microelectronic sensor for carry out said process
09/24/2009CA2718527A1 Kit for collecting blood, preferably peripheral blood, for the production of stem cells
09/24/2009CA2718092A1 Detection and prognosis of cervical cancer
09/24/2009CA2718011A1 Compositions and methods for analysis of nucleic acid molecules during amplification reaction using footprint probes
09/24/2009CA2717936A1 Markers and methods for assessing and treating severe or persistant asthma and tnf related disorders
09/24/2009CA2717489A1 Kit for detecting cancer cells metastasizing into sentinel lymph node
09/24/2009CA2711151A1 Detection of analytes using metal nanoparticle probes and dynamic light scattering
09/24/2009CA2710813A1 Molecular typing and subtyping of salmonella by identification of the variable nucleotide sequences of the crispr loci
09/23/2009EP2103694A1 Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
09/23/2009EP2103693A1 Nucleic acid amplification in the presence of modified randomers
09/23/2009EP2103692A1 Gene manipulation in the human PLK1 gene
09/23/2009EP2103688A2 Method for modifying plant morphology, biochemistry and physiology
09/23/2009EP2103616A1 Fluorescent molecule
09/23/2009EP2102773A2 Quantitative method employing adjustment of pre-defined master calibration curves
09/23/2009EP2102652A1 A method based on a breath test for the detection of pathogen microorganisms
09/23/2009EP2102651A2 Genetic analysis systems and methods
09/23/2009EP2102393A1 Polymorphisms predictive of platinum-coordinating complex-induced ototoxicity
09/23/2009EP2102392A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity
09/23/2009EP2102370A2 Method of monitoring hiv infection
09/23/2009EP2102369A1 Human diabetes susceptibility sema6d gene
09/23/2009EP2102368A1 Human diabetes susceptibility btbd9 gene
09/23/2009EP2102367A2 Methods for diagnosing and monitoring the status of systemic lupus erythematosus
09/23/2009EP2102366A2 Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
09/23/2009EP2102365A2 Enrichment through heteroduplexed molecules
09/23/2009EP2102364A2 Genetic markers for orobanche resistance in sunflower
09/23/2009EP2102363A2 Assays for fungal infection
09/23/2009EP2102362A2 Compositions and methods for detecting noonan syndrome
09/23/2009EP2102361A2 Dna methylation markers and methods of use
09/23/2009EP2102360A2 Ttk as tumor marker and therapeutic target for lung cancer
09/23/2009EP2102359A2 Detection of gene expression in cells by scanning fcs
09/23/2009EP2102358A1 Disposable articles for analysis and diagnostics for a laboratory
09/23/2009EP2102357A1 Ltbp2 as a biomarker, therapeutic and diagnostic target
09/23/2009EP2102356A2 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells
09/23/2009EP2102350A2 The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
09/23/2009EP2102237A2 Recombinant human factor ix and use thereof
09/23/2009EP2102232A2 Acyl-transferase
09/23/2009EP2102103A1 Method for detecting pyrophosphate by means of bioluminescence detection
09/23/2009EP2101747A2 Cancer chemoprevention strategy based on loss of imprinting of igf2
09/23/2009EP2101687A2 Biocompatible scaffold for sensing proteins
09/23/2009EP1812599B1 Methods and compositions for analysing ribonucleic acids
09/23/2009EP1787126B1 A procedure for characterization of a polyclonal cell line
09/23/2009EP1766047B1 Hif prolyl hydroxylase activity assay
09/23/2009EP1667715B1 Antigen delivery system
09/23/2009EP1558758B1 Molecular identification of aspergillus species